{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:19:22Z","timestamp":1789690762334,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002850","name":"FONDECYT","doi-asserted-by":"publisher","award":["1140968"],"award-info":[{"award-number":["1140968"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PIA Anillo","award":["ACT1411"],"award-info":[{"award-number":["ACT1411"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.bbrc.2016.09.054","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T22:02:33Z","timestamp":1473890553000},"page":"1078-1083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Possible role of mitochondrial permeability transition pore in the pathogenesis of Huntington disease"],"prefix":"10.1016","volume":"483","author":[{"given":"Rodrigo A.","family":"Quintanilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheril","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.09.054_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"T.H. s. D.C.R. Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.054_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.09.054_bib4","first-page":"237","article-title":"Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body","volume":"23","author":"Martin","year":"2008","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2016.09.054_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1749-6632.1999.tb07856.x","article-title":"Ca (2+)-dependent permeability transition and complex I activity in lymphoblast mitochondria from normal individuals and patients with Huntington's or Alzheimer's disease","volume":"893","author":"Panov","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2016.09.054_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington's disease pathogenesis. Insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2016.09.054_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410120504","article-title":"Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan","volume":"12","author":"Kuhl","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib10","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.054_bib11","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","article-title":"Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease","volume":"27","author":"Fernandes","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.054_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.20754","article-title":"Low stability of Huntington muscle mitochondria gainst Ca2+ in R6\/2 mice","volume":"59","author":"Gizatullina","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib13","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.M709555200","article-title":"Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats","volume":"283","author":"Gellerich","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.054_bib14","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1523\/JNEUROSCI.23-12-04858.2003","article-title":"Increased susceptibility of striatal mitochondria to calcium-induced permeability transition","volume":"23","author":"Brustovetsky","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.054_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-8-45","volume":"8","author":"Quintanilla","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbrc.2016.09.054_bib16","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.054_bib17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.054_bib18","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1093\/hmg\/ddq247","article-title":"Mitochondrial calcium uptake capacity as a therapeutic target in the R6\/2 mouse model of Huntington's disease","volume":"19","author":"Perry","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.054_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10495-007-0723-y","article-title":"The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis","volume":"12","author":"Rasola","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2016.09.054_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tcb.2016.04.006","article-title":"Mitochondrial permeability transition: new findings and persisting uncertainties","volume":"26","author":"Izzo","year":"2016","journal-title":"Trends cell Biol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/7854_2014_354","article-title":"The neuropathology of Huntington's disease","volume":"22","author":"Waldvogel","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.054_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington's disease","volume":"27","author":"Walker","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","article-title":"Treating the whole body in Huntington's disease","volume":"14","author":"Carroll","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ncl.2009.04.001","article-title":"Huntington disease and other choreas","volume":"27","author":"Cardoso","year":"2009","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.bbrc.2016.09.054_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0b013e3181eccfa2","article-title":"Mild cognitive impairment in prediagnosed Huntington disease","volume":"75","author":"Duff","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2016.09.054_bib26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/mds.22953","article-title":"Cognitive and functional decline in Huntington's disease: dementia criteria revisited","volume":"25","author":"Peavy","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.09.054_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","article-title":"Cognitive impairment in Huntington disease: diagnosis and treatment","volume":"11","author":"Paulsen","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bbrc.2016.09.054_bib28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"G.P. Bates, Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbrc.2016.09.054_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.brainresbull.2006.10.014","article-title":"Genetic criteria for Huntington's disease pathogenesis","volume":"72","author":"Gusella","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbrc.2016.09.054_bib30","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/hmg\/ddg156","article-title":"Huntingtin contains a highly conserved nuclear export signal","volume":"12","author":"Xia","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.054_bib31","first-page":"65","article-title":"The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology","volume":"5","author":"Schulte","year":"2011","journal-title":"Curr. Trends Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: new developments in Huntington's disease research","volume":"24","author":"Cattaneo","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.054_bib33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.054_bib34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.09.054_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington's disease","volume":"238","author":"Arrasate","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.mcn.2005.05.003","article-title":"Mutant huntingtin represses CBP, but not p300, by binding and protein degradation","volume":"30","author":"Cong","year":"2005","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.054_bib38","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.09.054_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.054_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","article-title":"Dopamine and glutamate in Huntington's disease: a balancing act","volume":"16","author":"Andre","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbrc.2016.09.054_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","article-title":"Excitotoxic neuronal death and the pathogenesis of Huntington's disease","volume":"39","author":"Estrada Sanchez","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bbrc.2016.09.054_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI45691","article-title":"Energy deficit in Huntington disease: why it matters","volume":"121","author":"Mochel","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2016.09.054_bib43","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","article-title":"Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease","volume":"283","author":"Lim","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.054_bib44","first-page":"129","article-title":"Mitochondrial dysfunction and Huntington disease","volume":"22","author":"Zhang","year":"2006","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bbrc.2016.09.054_bib45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2016.09.054_bib46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ana.410230603","article-title":"Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function","volume":"23","author":"Berent","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/WNL.24.9.813","article-title":"Biochemical abnormalities in Huntington's chorea brains","volume":"24","author":"Stahl","year":"1974","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2016.09.054_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib49","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","article-title":"Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry","volume":"11","author":"Ferrante","year":"1991","journal-title":"J.\u00a0Neurosci."},{"issue":"2015","key":"10.1016\/j.bbrc.2016.09.054_bib50","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1093\/brain\/awv290","article-title":"Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat","volume":"138","author":"Clemens","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2016.09.054_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Gen."},{"key":"10.1016\/j.bbrc.2016.09.054_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.054_bib53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1471-4159.2006.04361.x","article-title":"Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice","volume":"101","author":"Oliveira","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.054_bib54","first-page":"1","article-title":"Dysfunctional mitochondrial respiration in the striatum of the Huntington's disease transgenic R6\/2 mouse model","volume":"2","author":"Aidt","year":"2013","journal-title":"PLOS Curr. Huntingt. Dis."},{"key":"10.1016\/j.bbrc.2016.09.054_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw138","article-title":"Oxygen consumption deficit in Huntington disease mouse brain under metabolic stress","author":"Lou","year":"2016","journal-title":"Hum. Mol. Gen."},{"key":"10.1016\/j.bbrc.2016.09.054_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw133","article-title":"Oxidative metabolism and Ca 2+handling in isolated brain mitochondria and striatal neurons from R6\/2 mice, a model of Huntington's disease","author":"Hamilton","year":"2016","journal-title":"Hum. Mol. Gen."},{"key":"10.1016\/j.bbrc.2016.09.054_bib57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","article-title":"Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse","volume":"47","author":"Tabrizi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.054_bib58","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.09.054_bib59","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.09.054_bib60","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0003-9861(79)90372-2","article-title":"The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site","volume":"195","author":"Haworth","year":"1979","journal-title":"Archives Biochem. biophysics"},{"key":"10.1016\/j.bbrc.2016.09.054_bib61","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0003-9861(79)90373-4","article-title":"The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release","volume":"195","author":"Hunter","year":"1979","journal-title":"Arch Biochem. biophysics"},{"key":"10.1016\/j.bbrc.2016.09.054_bib62","doi-asserted-by":"crossref","DOI":"10.1007\/s10863-016-9652-1","article-title":"Physiological roles of the mitochondrial permeability transition pore","author":"Mnatsakanyan","year":"2016","journal-title":"J.\u00a0bioenerg. biomemb."},{"key":"10.1016\/j.bbrc.2016.09.054_bib63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/bbrc.1999.1696","article-title":"Potentiation by chronic ethanol treatment of the mitochondrial permeability transition","volume":"265","author":"Pastorino","year":"1999","journal-title":"Biochem. biophysical Res. Commun."},{"key":"10.1016\/j.bbrc.2016.09.054_bib64","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.phrs.2015.04.013","article-title":"Cell death disguised: the mitochondrial permeability transition pore as the c-subunit of the F(1)F(O) ATP synthase","volume":"99","author":"Jonas","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2016.09.054_bib65","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1253\/circj.CJ-13-0321","article-title":"Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore","volume":"77","author":"Elrod","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2016.09.054_bib66","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.bbadis.2013.09.003","article-title":"Mitochondrial permeability transition pore is a potential drug target for neurodegeneration","volume":"1842","author":"Rao","year":"2014","journal-title":"Biochimica biophysica acta"},{"key":"10.1016\/j.bbrc.2016.09.054_bib67","doi-asserted-by":"crossref","first-page":"10580","DOI":"10.1073\/pnas.1401591111","article-title":"An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore","volume":"111","author":"Alavian","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.09.054_bib68","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature03434","article-title":"Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death","volume":"434","author":"Baines","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.09.054_bib69","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2009.07.005","article-title":"Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta","volume":"1802","author":"Du","year":"2010","journal-title":"Biochimica biophysica acta"},{"key":"10.1016\/j.bbrc.2016.09.054_bib70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0006-3495(99)77239-5","article-title":"Transient and long-lasting openings of the mitochondrial permeability transition pore can Be monitored directly in intact cells by changes in mitochondrial calcein fluorescence","volume":"76","author":"Petronilli","year":"1999","journal-title":"Biophysical J."},{"key":"10.1016\/j.bbrc.2016.09.054_bib71","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.M709555200","article-title":"Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats","volume":"283","author":"Gellerich","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.054_bib72","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jnc.13165","article-title":"Ca 2+handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease","volume":"134","author":"Pellman","year":"2015","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.054_bib73","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.054_bib74","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1172\/JCI70911","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington's disease\u2013associated neurodegeneration","volume":"123","author":"Guo","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2016.09.054_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030406","article-title":"Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPAR\u03b3","volume":"7","author":"Jin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2016.09.054_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2015.09.008","article-title":"Mitochondrial dynamics and quality control in Huntington's disease","volume":"90","author":"Guedes-Dias","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbrc.2016.09.054_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/509654","article-title":"Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer's disease","volume":"2015","author":"Cabezas-Opazo","year":"2015","journal-title":"Oxid Med Cell Long"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16315145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16315145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T13:59:53Z","timestamp":1568383193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16315145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0006291X16315145"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.054","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible role of mitochondrial permeability transition pore in the pathogenesis of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}